Cargando...
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: challenges, considerations and strategy
Assorted challenges in physicochemical characterization, sterilization, depyrogenation, and in the assessment of pharmacology, safety, and efficacy profiles accompany preclinical development of nanotechnology-formulated drugs. Some of these challenges are not unique to nanotechnology and are common...
Gardado en:
| Publicado en: | J Control Release |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4688153/ https://ncbi.nlm.nih.gov/pubmed/26348388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2015.08.056 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|